CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the reference to our firm under the caption “Experts” in Amendment No. 3 to the Registration Statement (Form F-1 No. 333-259085) and related Prospectus of Can-Fite BioPharma Ltd. and to the incorporation by reference therein of our report dated March 30, 2023, with respect to the consolidated financial statements of Can-Fite BioPharma Ltd. included in its Annual Report (Form 20-F) for the year ended December 31, 2022, filed with the Securities and Exchange Commission.
|Tel-Aviv, Israel||/s/ KOST FORERR GABBAY & KASIERER|
|March 31, 2023||A Member of Ernst & Young Global|